Drug intelligence / Profile preview

thirst granule

Development stage: Preclinical
Lead developer: Tasly Pharmaceutical
Administration: Oral

Overview

Thirst granule is a Traditional Chinese Medicine (TCM) herbal composition developed by Tasly Pharmaceutical Group Co., LTD. It is composed of five traditional herbs: know mother (Zhi Mu), atractylodes (Cang Zhu), Coptis chinensis (Huang Lian), puhuang (Typha angustifolia), and ground brocade grass (Di Jin Cao). It is being investigated for its safety and effectiveness as an intervention for prediabetes.

Other names: 消渴清颗粒

Beyond the preview

Go deeper on thirst granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on thirst granule.

Explore the full profile